Uttarakhand suspends licence of 14 Patanjali products
The state regulator has suspended the manufacturing licence of 14 products of Patanjali Ayurved for "repeated violations" of rules.
The state regulator has suspended the manufacturing licence of 14 products of Patanjali Ayurved for "repeated violations" of rules.
The second public apology came following the SC rap, which ordered Patanjali Ayurved to submit a fresh public apology in court, without enlarging
“We want to see that when you issue an (apology) ad, it does not mean we have to see it by a microscope. It is not meant to be on papers, but also read," Justice Kohli said.
The SC bench, while hearing the misleading ad case against Ramdev and his associate Balkrishna, adjourned the case to April 24, 2024
Patanjali Foods says directions and observations of Supreme Court do not have any bearing on regular business operations
SC in February had asked Patanjali Ayurved to stop promoting and marketing ayurvedic products, which it claimed to cure critical illnesses
SC bars Patanjali Ayurved from promoting and marketing products that claim to cure critical illnesses like heart issues and asthma
Rajiv Jain-led GQG has acquired a 5.96% stake, or about 2.15 crore shares, in Patanjali Foods in the recently concluded offer for sale (OFS) of the FMCG company.
The OFS, at floor price of ₹1,000 apiece, will fetch around ₹3,258 crore to Baba Ramdev-led Patanjali Ayurved.
The four companies that will list on the bourses include - Patanjali Ayurved, Patanjali Medicine, Patanjali Wellness and Patanjali Lifestyle.